GTMUX
Price
$24.93
Change
-$0.08 (-0.32%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

GTMUX vs RPTIX

Header iconGTMUX vs RPTIX Comparison
Open Charts GTMUX vs RPTIXBanner chart's image
Goldman Sachs Small/Mid Cap Growth R6
Price$24.93
Change-$0.08 (-0.32%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GTMUX vs RPTIX Comparison Chart
Loading...
VS
GTMUX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTMUX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. GTMUX (1.84B). RPTIX pays higher dividends than GTMUX: RPTIX (0.18) vs GTMUX (0.00). GTMUX was incepted earlier than RPTIX: GTMUX (9 years) vs RPTIX (9 years). GTMUX is a more actively managed with annual turnover of: 62.00 vs. RPTIX (21.70). RPTIX has a lower initial minimum investment than GTMUX: RPTIX (500000) vs GTMUX (5000000). GTMUX annual gain was more profitable for investors over the last year : 28.19 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. GTMUX (11.45).
GTMUXRPTIXGTMUX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years9 years-
Gain YTD13.8379.127152%
Front LoadN/AN/A-
Min. Initial Investment50000005000001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.84B31.4B6%
Annual Yield % from dividends0.000.18-
Returns for 1 year28.1914.81190%
Returns for 3 years-21.10-13.57155%
Returns for 5 years11.4515.0976%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp